US20220023203A1 - Method for manufacturing medicated chewing gum without cooling - Google Patents
Method for manufacturing medicated chewing gum without cooling Download PDFInfo
- Publication number
- US20220023203A1 US20220023203A1 US17/499,348 US202117499348A US2022023203A1 US 20220023203 A1 US20220023203 A1 US 20220023203A1 US 202117499348 A US202117499348 A US 202117499348A US 2022023203 A1 US2022023203 A1 US 2022023203A1
- Authority
- US
- United States
- Prior art keywords
- composition
- weight
- total weight
- active ingredient
- gum base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015218 chewing gum Nutrition 0.000 title abstract description 112
- 229940112822 Chewing Gum Drugs 0.000 title abstract description 90
- 238000004519 manufacturing process Methods 0.000 title abstract description 60
- 238000001816 cooling Methods 0.000 title description 24
- 239000000203 mixture Substances 0.000 claims abstract description 250
- 239000004480 active ingredient Substances 0.000 claims abstract description 196
- 229920000591 gum Polymers 0.000 claims abstract description 192
- 239000000843 powder Substances 0.000 claims abstract description 138
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 74
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 64
- 239000003765 sweetening agent Substances 0.000 claims abstract description 64
- 235000000346 sugar Nutrition 0.000 claims description 166
- 239000003795 chemical substances by application Substances 0.000 claims description 58
- 239000010460 hemp oil Substances 0.000 claims description 54
- 229920000881 Modified starch Polymers 0.000 claims description 52
- 239000000314 lubricant Substances 0.000 claims description 52
- 235000019426 modified starch Nutrition 0.000 claims description 52
- 150000001298 alcohols Chemical class 0.000 claims description 42
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 34
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N Cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims description 32
- 229950011318 Cannabidiol Drugs 0.000 claims description 32
- QHMBSVQNZZTUGM-MSOLQXFVSA-N Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-MSOLQXFVSA-N 0.000 claims description 32
- 239000008121 dextrose Substances 0.000 claims description 28
- 150000008163 sugars Chemical class 0.000 claims description 28
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 22
- 239000004368 Modified starch Substances 0.000 claims description 22
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 22
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 22
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 22
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 14
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 claims description 14
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims description 14
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 14
- 239000004386 Erythritol Substances 0.000 claims description 14
- UNXHWFMMPAWVPI-ZXZARUISSA-N Erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 14
- 229940009714 Erythritol Drugs 0.000 claims description 14
- SERLAGPUMNYUCK-DCUALPFSSA-N Isomalt Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 14
- VQHSOMBJVWLPSR-WUJBLJFYSA-N Maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 14
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 14
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 14
- 229960002675 Xylitol Drugs 0.000 claims description 14
- 235000019414 erythritol Nutrition 0.000 claims description 14
- 239000000905 isomalt Substances 0.000 claims description 14
- 235000010439 isomalt Nutrition 0.000 claims description 14
- 239000000845 maltitol Substances 0.000 claims description 14
- 235000010449 maltitol Nutrition 0.000 claims description 14
- 229940035436 maltitol Drugs 0.000 claims description 14
- 239000000594 mannitol Substances 0.000 claims description 14
- 235000010355 mannitol Nutrition 0.000 claims description 14
- 229960001855 mannitol Drugs 0.000 claims description 14
- 239000000600 sorbitol Substances 0.000 claims description 14
- 235000010356 sorbitol Nutrition 0.000 claims description 14
- 239000000811 xylitol Substances 0.000 claims description 14
- 235000010447 xylitol Nutrition 0.000 claims description 14
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims description 12
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 12
- 229920001661 Chitosan Polymers 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 6
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims description 6
- 229960001948 caffeine Drugs 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 229940045110 Chitosan Drugs 0.000 claims 2
- 239000000796 flavoring agent Substances 0.000 abstract description 56
- 235000019634 flavors Nutrition 0.000 abstract description 56
- 238000002156 mixing Methods 0.000 abstract description 54
- 239000003607 modifier Substances 0.000 abstract description 32
- 238000003801 milling Methods 0.000 abstract description 22
- 238000010438 heat treatment Methods 0.000 abstract description 20
- 239000002585 base Substances 0.000 description 118
- 235000019441 ethanol Nutrition 0.000 description 78
- 239000003921 oil Substances 0.000 description 74
- 238000010586 diagram Methods 0.000 description 32
- 239000004615 ingredient Substances 0.000 description 30
- 238000000034 method Methods 0.000 description 30
- 239000002245 particle Substances 0.000 description 28
- 229940033529 Tetrahydrocannabinol Drugs 0.000 description 26
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 26
- 229960004242 dronabinol Drugs 0.000 description 26
- 230000001143 conditioned Effects 0.000 description 22
- 238000000227 grinding Methods 0.000 description 22
- 239000007788 liquid Substances 0.000 description 22
- 230000003750 conditioning Effects 0.000 description 20
- 239000000470 constituent Substances 0.000 description 20
- -1 flavoring Substances 0.000 description 16
- UHZZMRAGKVHANO-UHFFFAOYSA-M 2-chloroethyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 12
- 239000008187 granular material Substances 0.000 description 10
- 239000001913 cellulose Substances 0.000 description 8
- 235000010980 cellulose Nutrition 0.000 description 8
- 229920002678 cellulose Polymers 0.000 description 8
- 229920001971 elastomer Polymers 0.000 description 8
- 239000000806 elastomer Substances 0.000 description 8
- 239000000969 carrier Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000007710 freezing Methods 0.000 description 6
- 239000004482 other powder Substances 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000006057 Non-nutritive feed additive Substances 0.000 description 4
- 230000000111 anti-oxidant Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000004067 bulking agent Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000005712 crystallization Effects 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 239000003979 granulating agent Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000006011 modification reaction Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000011236 particulate material Substances 0.000 description 4
- 239000004014 plasticizer Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229940081528 Caffeine Chewing Gum Drugs 0.000 description 2
- 240000006583 Eucalyptus mannifera Species 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 238000005296 abrasive Methods 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 2
- 229910000316 alkaline earth metal phosphate Inorganic materials 0.000 description 2
- 230000002149 cannabinoid Effects 0.000 description 2
- 229930003827 cannabinoid Natural products 0.000 description 2
- 239000003557 cannabinoid Substances 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000007907 direct compression Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000002632 lipids Chemical group 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 229920001206 natural gum Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/066—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the fat used
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/08—Chewing gum characterised by the composition containing organic or inorganic compounds of the chewing gum base
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
An improved method for manufacture of chewing gums containing active ingredient(s) that preserves the efficacy of the active ingredient(s) by avoiding exposure to high heat and extreme cold during milling that can otherwise degrade the active's efficacy. A chewing gum base is used, along with one or more therapeutically-active ingredients, one or more sweeteners (alcohol-based and/or natural), and one or more flavorings and optional flavor modifiers. The method generally comprises heating the gum base in ovens to melt the gum base. Separately, the active ingredient(s), sweeteners and flavorings are combined in a mixer. The melted gum base is added to the mixer and cools to produce a particulate mixture. As mixing continues the mass cools to room temperature and forms granular pieces. The granular pieces are ground into a powder at room temperature, mixed at room temperature with tableting excipients, and tableted. Several variations on the foregoing are also described.
Description
- In accordance with 37 CFR § 1.76, a claim of priority is included in an Application Data Sheet filed concurrently herewith. Accordingly, the present invention claims priority as a divisional of U.S. patent application Ser. No. 14/732,072, entitled “METHOD FOR MANUFACTURING MEDICATED CHEWING GUM WITHOUT COOLING”, filed Jun. 5, 2015, which claims priority to U.S. Provisional Patent Application No. 62/008,211, filed Jun. 5, 2014.
- The present invention relates generally to the manufacture of chewing gums containing active ingredients and, more specifically, to a method for manufacture of such chewing gums that preserves the efficacy of the active ingredient(s).
- The conventional methods of producing compressible chewing gums entail freezing the gum base and then grinding to obtain a particulate material, mixing the particulate material with other materials (usually in particulate form), then pressing the compressible chewing gum mixture into tablets.
- For example, U.S. Pat. No. 4,370,350 to Fisher et al. (Wrigley) issued Jan. 25, 1983 shows a method for the manufacture of chewing gum in which the viscosity of the gum base is first reduced by heating. A bulking agent is then added to the gum base while mixing. The mixture is cooled during mixing to form granules. More bulking agent is added to form layers around the granules, and there is no active ingredient nor any grinding or tableting.
- For example, U.S. Pat. No. 7,101,579 to Athanikar et al. (Deseret Labs) issued Sep. 5, 2006 shows a chewing gum composition containing an active ingredient. The gum base is cooled to a temperature at which the composition is brittle, ground, mixed with the active ingredient as desired, and formed into a tablet.
- U.S. Pat. No. 5,711,961 to Reiner et al. (APR Applied Pharma) issued Jan. 27, 1998 discloses a pharmaceutical chewing gum composition in tablet form made by freezing, grinding the gum in a mill, and granulating the ground gum in a fluid bed. Thereafter, a medicinal active agent is mixed with the granulate, and the granulates are compressed into tablets. This patent is provided for general interest.
- U.S. Pat. No. 4,975,270 to Kehoe (Nabisco) issued 4 Dec. 1990 shows a medicament-active chewing gum made by freezing and grinding into a particle. Note that the gum and the active ingredient are mixed together while heating, and then the mixture is frozen and ground into particles.
- U.S. Pat. No. 6,582,738 to Gubler (Deseret Laboratories) issued Jun. 24, 2003 shows a process for preparing chewing gum containing a nutritional supplement that includes cooling and grinding the cooled, brittle gum composition to form a chewing gum powder, mixing with an active nutritional supplement, granulating, and then compressing the granules to form chewing gum tablets. The chewing gum composition is cooled to a temperature at which the gum composition is brittle.
- Alternatively it is known to mix a powder sweetener into a molten gum base while subjecting the mixture to shear (i.e., through the mixing force) and cooling. This technique causes the grinding as the mixture becomes more rigid due to cooling and the addition of the dry sweetener.
- U.S. Pat. No. 4,753,805 to Cherukuri et al. (Warner-Lambert) issued Jun. 28, 1988 shows a tabletted chewing gum composition and method of preparation in which a gum base is mixed with a sweetener, and the mixture is ground with an abrasive grinding aid (alkali metal phosphates, alkaline earth metal phosphates, maltodextrins).
- U.S. Pat. No. 7,208,186 (SPI Pharma, Inc.) to Norman et al. issued Apr. 24, 2007 shows a chewing gum formulation with an active ingredient. The gum base, granulating agent and a processing aid are mixed until in particulate form. The temperature in the mixer is then increased to a temperature which is sufficient to melt at least the surface of the gum base particles and the contents of the mixer are mixed for several minutes at this temperature to obtain a uniform mixture of the gum base, the granulating agent and the processing aid in particulate form particles inside the mixer. Next, the active ingredient is added to the particles and most or all of the active ingredient is loosely bound to the outer surfaces of the particles. The particles are tableted. There is no cooling necessary to make the chewing gum formulation friable.
- U.S. Pat. No. 7,351,438 to Sozzi et al. (Gum Base Co., SPA) issued Apr. 1, 2008 shows a method of preparing chewing gum in tablet form by direct compression of the chewing gum formulation in powder form. The chewing gum in powder form is produced by a method which comprises the following steps:
- a) mixing of a soft basic gum with at least one sweetener and, optionally, at least one other typical chewing-gum ingredient, at a temperature of between 35 and 75° C., b) cooling of the mixture thus obtained to a temperature of between 0 and −40° C. and preferably between −10 and −40° C.,
-
- c) grinding and subsequent screening of the mixture thus obtained to a particle size of less than 10 mesh,
- d) optional mixing of the powder thus obtained with at least one anti-agglutination agent, e) optional compression of the mixture thus obtained.
- U.S. Pat. No. 5,866,179 to Testa (Avant-Garde Technologies) issued Feb. 2, 1999 shows a medicated chewing gum and a process for preparation thereof in which the active agent is mixed with a granulated gum base under controlled temperature and humidity and the blended components are cold-pressed to produce a final gum product. The gum base is prepared by cooling natural gum to −10 degree C., then grinding it. It is noted that the elevated temperatures used in the melt can adversely affect the chemical stability of the therapeutic agent.
- Neither prior method is optimal for chewing gums with active ingredients since heating and/or cooling can erode the effectiveness of the active. The proposed process avoids this by initially heating a gum base to slightly elevated internally measured temperature between 140-160 deg F. in ovens, mixing with the active as it cools to produce a particulate mixture, grinding into compressible powder, then forming into tablets. The temperature of the gum base exceeds that of the mixer when first introduced, but as mixing continues it cools and mixes into a particulate form inside the mixer. Next, the particulate is ground into compressible powder at room temperature, mixed at room temperature with excipients, and tableted. This avoids heating/cooling of the active and preserves its efficacy.
- It is an object of the invention to provide an improved method for manufacture of chewing gums containing active ingredients that preserves the efficacy of the active ingredient(s).
- It is another object to provide a method for manufacture of chewing gums containing active ingredients that avoids exposure of the active ingredients to high heat during mixing that can degrade the active's efficacy.
- It is another object to provide a method for manufacture of chewing gums containing active ingredients that avoids exposure of the active ingredients to extreme cold during milling that can degrade the active's efficacy.
- It is another object to provide a method for manufacture of chewing gums containing active ingredients in which the active in oil form can be mixed directly into the other powder ingredients and tableted, rather than spray-dried onto a powder carrier for tableting as with the prior art methods. This direct mixing of the oil into the powder can deliver more active ingredient with less weight than the alternatives thus making the tableting process more efficient and less expensive
- In accordance with the foregoing objects, present invention provides an improved method for manufacture of chewing gums containing active ingredients that preserves the efficacy of the active ingredient(s) by avoiding exposure to high heat and extreme cold during milling that can otherwise degrade the active's efficacy. A suitable chewing gum base is used preferably comprising one or more constituents including elastomers for elasticity, resins to act as binders and softeners, plasticizers to render the elastomer soft to ensure thorough blending of the gum base, fillers contributing to the overall texture, and antioxidants to prevent oxidation of the gum base and flavors during shelf life. In addition, one or more therapeutically-active ingredients are used, one or more sweeteners (alcohol-based and/or natural), and one or more flavorings and optional flavor modifiers are used.
- Generally, the method comprises initially heating the gum base in ovens to melt the gum base to an internally measured temperature between 140-160 deg F. Separately, powdered ingredients including one or more active ingredient(s), sweeteners and flavorings are combined in a mixer. The melted gum base is added to the mixer and cools to produce a particulate mixture. The temperature of the gum base exceeds that of the mixer when first introduced, but as mixing continues it cools quickly to room temperature and forms granular pieces. The granular pieces are conditioned for a period of time. Conditioning is the time between the mixing and grinding of the gum. Conditioning allows the granular pieces to dry slightly and complete the crystallization process. Next, the granular pieces are ground into a powder at room temperature, mixed at room temperature with tableting excipients, and tableted. This process avoids extreme heating or cooling of the active ingredient(s) and preserves the efficacy.
- The present invention including several embodiments is described in greater detail in the detailed description of the invention, and the appended drawings. Additional features and advantages of the invention will be set forth in the description that follows, will be apparent from the description, or may be learned by practicing the invention.
- Other objects, features, and advantages of the present invention will become more apparent from the following detailed description of the preferred embodiments and certain modifications thereof when taken together with the accompanying drawings in which:
-
FIG. 1 is a process flow diagram of a first embodiment of the method for manufacturing chewing gum according to the invention, suited for active ingredient(s) that are provided in powder form. -
FIG. 2 is a process flow diagram of a second embodiment of a method for manufacturing chewing gum according to the invention, likewise suited for active ingredient(s) that are provided in powder form. -
FIG. 3 is a process flow diagram of a third embodiment of the method for manufacturing chewing gum according to the invention, suited for active ingredient(s) that are provided in oil form. -
FIG. 4 is a process flow diagram of a fourth embodiment of the method for manufacturing chewing gum according to the invention, suited for active ingredient(s) that are provided in oil form. -
FIG. 5 is a process flow diagram of a fifth embodiment of the method for manufacturing chewing gum according to the invention, suited for active ingredient(s) that are provided in oil form. -
FIG. 6 is a flow diagram of a sixth embodiment of the method for manufacturing chewing gum according to the invention, suited for active ingredient(s) that are provided in oil form. -
FIG. 7 is a process flow diagram of a seventh embodiment of the method for manufacturing chewing gum according to the invention, suited for active ingredient(s) that are provided in oil form. -
FIG. 8 is a flow diagram of a eighth embodiment of the method for manufacturing chewing gum according to the invention, suited for active ingredient(s) that are provided in oil form. - Reference will now be made in detail to preferred embodiments of the present invention, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
- For purposes of description, the term “active” is herein defined as the ingredient or ingredients that provide a therapeutic effect. In the present invention active(s) may be provided in either powder or oil form. An active in oil form is defined as a free flowing liquid, semi-solid, or paste that is lipid-based and not water soluble. In the case of a semi-solid or paste, when heated to a maximum temperature of 140 deg F., the material changes to an oil. Active ingredients in oil form can include hemp oil, THC resin, any cannabinoid oil, as well as pharmaceutical actives, botanicals and essential oils.
- The invention generally is an improved method for manufacture of chewing gums containing active ingredients that preserves the efficacy of the active ingredient(s) by avoiding exposure to high heat and extreme cold, mainly during milling, that can otherwise degrade the active's efficacy. A suitable chewing gum base is used comprising one or more constituents including elastomers for elasticity, resins to act as binders and softeners, plasticizers to render the elastomer soft to ensure thorough blending of the gum base, fillers contributing to the overall texture, and antioxidants to prevent oxidation of the gum base and flavors during shelf life.
- Generally, the method comprises initially heating the gum base in ovens to melt the gum base to an internally measured temperature between 140-160 deg F. Ingredients, including one or more active ingredient(s), are combined in a mixer. The melted gum base is added to the mixer and cools to produce a particulate mixture. The temperature of the gum base exceeds that of the mixer when first introduced, but as mixing continues it cools quickly to room temperature and forms rock-sized granular pieces. These granular pieces are then conditioned for a period of time, which allows the granular pieces to dry slightly and complete the crystallization process. Preferably, the pieces are conditioned for at least 6 hours at a temperature not greater than 75 deg. F. and 60% relative humidity. Next, the pieces are ground into a powder at room temperature, mixed at room temperature with tableting excipients, and tableted. This avoids extreme heating or cooling of the active ingredient(s) and preserves the efficacy.
- The active ingredients may be provided in raw powder or oil form, and the present application suggests two alternative methods one suited for the powder form and one for the oil form. When the active ingredient(s) is in oil form, the oil can be mixed directly into the other powder ingredients and tableted, and there is no need for spray-drying the oil onto a powder carrier for tableting as with the prior art methods. This direct mixing delivers more active ingredient with less weight thus making the tableting process more efficient and less expensive.
-
FIG. 1 is a flow diagram of the method for manufacturing chewing gum according to an embodiment of the invention suited for active ingredient(s) in powder form. - At step 105 one or more different gum base(s) are placed in trays lined with a sugar alcohol and the trays are placed in an oven. The gum base is melted until it reaches an internally measured temperature between 140-160 deg F. Temperature may be measured with a commercial food thermometer.
- At step 100, in a commercial mixer, preferably a double Z-blade mixer (for example, a WINKWORTH® double blade Z blender), the active ingredient(s), the sugar alcohols, flavors and flavor modifiers are added and mixed approximately 3 to 7 minutes.
- At step 110 the melted gum base is added into the mixer and mixed until a homogeneous mass is produced. The mixing time may vary within a range of from 2 to 6 minutes.
- At step 120 the mass is removed from the blender and conditioned in trays for a minimum of 6 hours at a temperature not greater than 75 deg F. and 60% relative humidity.
- At step 130, after the conditioning period, the gum is milled into particulates at room temperature using a hammer mill that forces the particulates through a mesh screen of appropriate predetermined particle size ranging between 0.10 inch to 0.30 inch with an optimal size of 0.24 inch.
- Optionally, at step 135 other active ingredients, flavor modifiers, or the like may be added.
- At step 140 the resulting powder is placed in an orbital or planetary mixer and the flow agents and tablet lubricants are added. The powder is blended for approximately 2 to 4 minutes.
- At step 150 the powder is tableted using standard tablet punches on any suitable commercial tablet press.
- The foregoing method entirely avoids exposure of the active ingredient to high heat or extreme cold during milling that would otherwise degrade the active's efficacy.
-
FIG. 2 is a flow diagram of the method for manufacturing chewing gum according to another embodiment of the invention, also suited for active ingredient(s) in powder form. - At step 205 one or more different gum base(s) are placed in trays lined with a sugar and the trays are placed in an oven. The gum base is melted until it reaches an internally measured temperature between 140-160 deg F.
- At step 200, in a commercial mixer, preferably a double Z-blade mixer (for example, a Winkworth® double blade Z blender), the active ingredient(s), the sugars, flavors and flavor modifiers are added and mixed approximately 3 to 7 minutes.
- At step 210 the melted gum base is added into the mixer and mixed until a homogeneous mass is produced. The mixing time may vary within a range of from 2 to 6 minutes.
- At step 220 the mass is removed from the blender and conditioned in trays for a minimum of 6 hours at a temperature not greater than 75 deg F. and 60% relative humidity.
- At step 230, after the conditioning period, the gum is milled into particulates at room temperature using a hammer mill that forces the particulates through a mesh screen of appropriate particle size ranging between 0.10 inch to 0.30 inch with an optimal size of 0.24 inch.
- Optionally, at step 235 other active ingredients, flavor modifiers, or the like may be added.
- At step 240 the resulting powder is placed in an orbital or planetary mixer and the flow agents and tablet lubricants are added. The powder is blended for approximately 2 to 4 minutes.
- At step 250 the powder is tableted using standard tablet punches on any suitable commercial tablet press.
- The foregoing method entirely avoids exposure of the active ingredient to high heat or extreme cold during milling that would otherwise degrade the active's efficacy.
-
FIG. 3 is a flow diagram of a method for manufacturing chewing gum according to an alternate embodiment of the invention suited for active ingredient(s) that are provided in oil form. - At step 305 a pre-mix consisting of the active(s) and a portion of the sweeteners comprising approximately 9 to 13% of one or more sugar alcohols (see Table 1, 3, 5, 6 below) are mixed in a suitable commercial orbital mixer. These ingredients are mixed approximately 3 to 9 minutes, until a homogeneous mix is obtained.
- Separately, at step 300 in a double blade Z blender, the balance of the sweeteners (the remaining 87-91% of the sugar alcohol(s), plus the flavors and flavor modifiers are added and mixed approximately 3 to 7 minutes.
- At step 310 the premix containing the active oil(s) is added to the blender and is mixed approximately 2 to 5 minutes.
- At step 315 one or more different gum base(s) are placed in trays lined with a sugar alcohol and the trays are placed in an oven. The gum base is melted until it reaches an internally measured temperature between 140-160 deg F.
- At step 320 the melted gum base is added into the mixer and mixed until a homogeneous mass is produced. The mixing time may vary within a range of from 2 to 6 minutes.
- At step 330 the mass is removed from the blender and conditioned in trays for a minimum of 6 hours at a temperature not greater than 75 deg F. and 60% relative humidity.
- At step 340, after the conditioning period, the gum is milled into particulates at room temperature using a hammer mill that forces the particulates through a mesh screen of appropriate pre-determined particle size ranging between 0.10 inch to 0.30 inch with an optimal size of 0.24 inch.
- Optionally, at step 345 flavor modifiers may be added.
- At step 350 the resulting powder is placed in an orbital or planetary mixer and the flow agents and tablet lubricants are added. The powder is blended for approximately 2 to 4 minutes.
- At step 360 the powder is tableted using standard tablet punches on any suitable commercial tablet press.
- As above this method entirely avoids exposure of the active ingredient to high heat or extreme cold during milling that would otherwise degrade the active's efficacy.
-
FIG. 4 is a flow diagram of a method for manufacturing chewing gum according to an alternate embodiment of the invention suited for active ingredient(s) that are provided in oil form. - At step 405 a pre-mix consisting of the active(s) and a portion of the sweeteners comprising approximately 9 to 13% of one or more sugars (see Tables 2, 4 below) are mixed in a suitable commercial orbital mixer. These ingredients are mixed approximately 3 to 9 minutes, until a homogeneous mix is obtained.
- Separately, at step 400 in a double blade Z blender, the balance of the sugars (the remaining 87-91%), plus flavors and flavor modifiers are added and mixed approximately 3 to 7 minutes.
- At step 410 the premix containing the active oil(s) is added to the blender and is mixed approximately 2 to 5 minutes.
- At step 415 one or more different gum base(s) are placed in trays lined with a sugar and the trays are placed in an oven. The gum base is melted until it reaches an internally measured temperature between 140-160 deg F.
- At step 420 the melted gum base is added into the mixer and mixed until a homogeneous mass is produced. The mixing time may vary within a range of from 2 to 6 minutes.
- At step 430 the mass is removed from the blender and conditioned in trays for a minimum of 6 hours at a temperature not greater than 75 deg F. and 60% relative humidity.
- At step 440, after the conditioning period, the gum is milled into particulates at room temperature using a hammer mill that forces the particulates through a mesh screen of appropriate particle size ranging between 0.10 inch to 0.30 inch with an optimal size of 0.24 inch.
- Optionally, at step 445 flavor modifiers may be added.
- At step 450 the resulting powder is placed in an orbital or planetary mixer and the flow agents and tablet lubricants are added. The powder is blended for approximately 2 to 4 minutes.
- At step 460 the powder is tableted using standard tablet punches on any suitable commercial tablet press.
- As above this method entirely avoids exposure of the active ingredient to high heat or extreme cold during milling that would otherwise degrade the active's efficacy.
-
FIG. 5 is a flow diagram of a method for manufacturing chewing gum according to an alternate embodiment of the invention suited for active ingredient(s) that are provided in oil form. - At step 505 a pre-mix consisting of the active(s) and a portion of the total sweeteners, e.g., approximately 9 to 13% of one or more of sugar alcohol, microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquisolid system (see Table 1, 3, 5, 6 below) are mixed in a suitable commercial orbital mixer. These ingredients are mixed approximately 3 to 9 minutes, until a homogeneous mix is obtained.
- Separately, at step 500 in a double blade Z blender, the balance of the sugar alcohols (the remaining 87-91% of the sugar alcohol(s), plus the entirety of the flavors and flavor modifiers are added and mixed approximately 3 to 7 minutes.
- At step 510 the premix containing the active oil(s) is added to the blender and is mixed approximately 2 to 5 minutes.
- At step 515 one or more different gum base(s) are placed in trays lined with a sugar alcohol and the trays are placed in an oven. The gum base is melted until it reaches an internally measured temperature between 140-160 deg F.
- At step 520 the melted gum base is added into the mixer and mixed until a homogeneous mass is produced. The mixing time may vary within a range of from 2 to 6 minutes.
- At step 530 the mass is removed from the blender and conditioned in trays for a minimum of 6 hours at a temperature not greater than 75 deg F. and 60% relative humidity.
- At step 540, after the conditioning period, the gum is milled into particulates at room temperature using a hammer mill that forces the particulates through a mesh screen of appropriate particle size ranging between 0.10 inch to 0.30 inch with an optimal size of 0.24 inch.
- Optionally, at step 545 flavor modifiers may be added.
- At step 550 the resulting powder is placed in an orbital or planetary mixer and the flow agents and tablet lubricants are added. The powder is blended for approximately 2 to 4 minutes.
- At step 560 the powder is tableted using standard tablet punches on any suitable commercial tablet press.
- As above this method entirely avoids exposure of the active ingredient to high heat or extreme cold during milling that would otherwise degrade the active's efficacy.
-
FIG. 6 is a flow diagram of a method for manufacturing chewing gum according to an alternate embodiment of the invention suited for active ingredient(s) that are provided in oil form. - At step 600 in a double blade Z blender, the sugar alcohols, flavors and flavor modifiers are added and mixed approximately 3 to 7 minutes, and the active oil(s) is added to the blender and is mixed approximately 2 to 5 minutes.
- At step 605 one or more different gum base(s) are placed in trays lined with a sugar alcohol and the trays are placed in an oven. The gum base is melted until it reaches an internally measured temperature between 140-160 deg F.
- At step 610 the melted gum base is added into the mixer and mixed until a homogeneous mass is produced. The mixing time may vary within a range of from 2 to 6 minutes.
- At step 620 the mass is removed from the blender and conditioned in trays for a minimum of 6 hours at a temperature not greater than 75 deg F. and 60% relative humidity.
- At step 630, after the conditioning period, the gum is milled into particulates at room temperature using a hammer mill that forces the particulates through a mesh screen of appropriate particle size ranging between 0.10 inch to 0.30 inch with an optimal size of 0.24 inch.
- At step 635 a pre-mix consisting of the active(s) and approximately 9 to 13% of a portion of the sweeteners, e.g., one or more of sugar alcohol, microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquisolid systems (see Table 1, 3, 5, 6 below) are mixed in a suitable commercial orbital or planetary mixer. These ingredients are mixed approximately 3 to 9 minutes, until a homogeneous mix is obtained.
- At step 640 the resulting powder is placed in an orbital or planetary mixer, the flow agents and any flavor modifiers are added. The powder is blended for approximately 3 to 8 minutes.
- At step 650 the milled gum powder is placed in an orbital or planetary mixer and the pre-mix and tablet lubricants are added. The powder is blended for approximately 3 to 5 minutes.
- At step 660 the powder is tableted using standard tablet punches on any suitable commercial tablet press.
- As above this method entirely avoids exposure of the active ingredient to high heat or extreme cold during milling that would otherwise degrade the active's efficacy.
-
FIG. 7 is a flow diagram of a method for manufacturing chewing gum according to an alternate embodiment of the invention suited for active ingredient(s) that are provided in oil form. - At step 700 in a double blade Z blender, the sugar alcohols, flavors and flavor modifiers are added and mixed approximately 3 to 7 minutes.
- At step 705 one or more active oil(s) is/are added to the blender and are mixed approximately 2 to 5 minutes.
- At step 710 one or more different gum base(s) are placed in trays lined with a sugar alcohol and the trays are placed in an oven. The gum base is melted until it reaches an internally measured temperature between 140-160 deg F.
- At step 720 the melted gum base is added into the mixer and mixed until a homogeneous mass is produced. The mixing time may vary within a range of from 2 to 6 minutes.
- At step 730 the mass is removed from the blender and conditioned in trays for a minimum of 12 hours.
- At step 740, after the conditioning period, the gum is extruded through a die to form the desired shape of the gum.
- Optionally, at step 750 a coating of a sugar alcohol can be applied to the gum piece.
-
FIG. 8 is a flow diagram of a method for manufacturing chewing gum according to an alternate embodiment of the invention suited for active ingredient(s) that are provided in oil form. - At step 800 a pre-mix consisting of the active(s) and a portion of the total sweeteners, e.g., approximately 9 to 13% of one or more of sugar alcohol, liquid flavors, microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquisolid system (see Table 1, 3, 5, 6 below) are mixed in a suitable commercial orbital mixer. These ingredients are mixed approximately 3 to 9 minutes, until a homogeneous mix is obtained. Separately, at step 805 in a double blade Z blender, the balance of the sugar alcohols (the remaining 87-91% of the sugar alcohol(s), plus the flavors and flavor modifiers are added and mixed approximately 3 to 7 minutes.
- At step 810 the premix containing the active oil(s) is added to the blender and is mixed approximately 2 to 5 minutes.
- At step 815 one or more different gum base(s) are placed in trays lined with a sugar alcohol and the trays are placed in an oven. The gum base is melted until it reaches an internally measured temperature between 140-160 deg F.
- At step 820 the melted gum base is added into the mixer and mixed until a homogeneous mass is produced. The mixing time may vary within a range of from 2 to 6 minutes.
- At step 830 the mass is removed from the blender and conditioned in trays for a minimum of 12 hours.
- At step 840, after the conditioning period, the gum is extruded through a die to form the desired shape of the gum.
- Optionally, at step 845 a coating of a sugar alcohol can be applied to the gum piece.
- As above this method entirely avoids exposure of the active ingredient to high heat or extreme cold that would otherwise degrade the active's efficacy.
- The following examples provide specific ingredient listings including a range of acceptable weight % and preferred weight % for ingredients used in the above-described processes for manufacturing particular gums having maximum efficacy.
- The foregoing method of
FIG. 1 has been used successfully to produce a tableted gum with a powdered active ingredient, for example chitosan, using the relative amounts of constituents (sugar alcohol, gum base, flavoring, active ingredient/chitosan, tableting lubricants and powder flow agents, and sweeteners) as shown in Table 1: -
TABLE 1 Weight % Optimal Range Weight % A sugar alcohol or a blend of sugar alcohols 42.4-75.3 64.0 that can include one or more of the following: sorbitol, isomalt, xylitol, maltitol, mannitol or erythritol Gum Base 20.0-30.0 25.7 Flavoring in liquid and powder 2.0-12.0 3.3 Active ingredient(s)—chitosan 1.0-20.0 2.5 Tableting lubricants and powder flow agents 1.5-5.0 4.0 Intensive sweeteners 0.2-0.6 0.5 Total 100.0 - The foregoing method of
FIG. 2 has been used successfully to produce a tableted gum with a powdered active ingredient, for example caffeine, using the relative amounts of constituents (sugar, gum base, flavoring, active ingredient/caffeine, tableting lubricants and powder flow agents, and sweeteners) as shown in Table 2: -
TABLE 2 Weight % Optimal Range Weight % A sugar or a blend of sugars that can include 55.0-70.0 59.6 one or more of the following: dextrose, sucrose, fructose, glucose Gum Base 20.0-30.0 21.2 Flavoring in liquid and powder 8.0-15.0 9.8 Active ingredient(s)—caffeine 1.0-10.0 4.7 Tableting lubricants and powder flow agents 2.6-5.0 3.7 Intensive sweeteners 0.2-1.5 1.0 Total 100.0 - The foregoing method of
FIG. 3 has been used successfully to produce a tableted gum with an oil-form active ingredient, for example concentrated hemp oil that delivers cannabidiol (CBD) or with a resinous oil that delivers tetrahydrocannabinol (THC). The relative amounts of constituents (sugar alcohol, gum base, flavoring, active ingredient/hemp oil, tableting lubricants and powder flow agents, and sweeteners) as shown in Table 3: -
TABLE 3 Weight % Optimal Range Weight % A sugar alcohol or a blend of sugar alcohols 48.4-68.8 57.8 that can include one or more of the following: sorbitol, isomalt, xylitol, maltitol, mannitol or erythritol Gum Base 20.0-30.0 28.5 Flavoring in liquid and powder 9.0-11.0 6.9 Active ingredient(s)—hemp oil 0.5-10.0 2.5 Tableting lubricants and powder flow agents 1.5-5.0 3.8 Intensive sweeteners 0.2-0.6 0.5 Total 100.0 - The foregoing method of
FIG. 4 has been used successfully to produce a tableted gum with an oil-form active ingredient, for example concentrated hemp oil that delivers cannabidiol (CBD) or with a resinous oil that delivers tetrahydrocannabinol (THC). The relative amounts of constituents (sugars, gum base, flavoring, active ingredient/hemp oil, tableting lubricants and powder flow agents, and sweeteners) as shown in Table 4: -
TABLE 4 Weight % Optimal Range Weight % A sugar or a blend of sugars that can include 53.0-70.0 62.9 one or more of the following: dextrose, sucrose, fructose, glucose Gum Base 20.0-30.0 28.6 Flavoring in liquid and powder 2.5-4.5 3.6 Active ingredient(s)—hemp oil 0.5-10.0 0.9 Tableting lubricants and powder flow agents 1.5-5.0 3.5 Intensive sweeteners 0.2-0.6 0.5 Total 100.0 - The foregoing method of
FIG. 5 has been used successfully to produce a tableted gum with an oil-form active ingredient, for example concentrated hemp oil that delivers cannabidiol (CBD) or with a resinous oil that delivers tetrahydrocannabinol (THC). The relative amounts of constituents (sugar alcohol, cellulose/starch derivatives, gum base, flavoring, active ingredient/hemp oil, tableting lubricants and powder flow agents, and sweeteners) as shown in Table 5: -
TABLE 5 Weight % Optimal Range Weight % A sugar alcohol or a blend of sugar alcohols 48.4-68.8 57.8 that can include one or more of the following: sorbitol, isomalt, xylitol, maltitol, mannitol or erythritol and one or more of the following: microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquidsolid system. Gum Base 20.0-30.0 28.5 Flavoring in liquid and powder 5.0-11.0 6.9 Active ingredient(s)—hemp oil 0.5-10.0 2.5 Tableting lubricants and powder flow agents 1.5-5.0 3.8 Intensive sweeteners 0.2-0.6 0.5 Total 100.0 - The foregoing method of
FIG. 6 has been used successfully to produce a tableted gum with an oil-form active ingredient, for example concentrated hemp oil that delivers cannabidiol (CBD) or with a resinous oil that delivers tetrahydrocannabinol (THC). The relative amounts of constituents (sugar alcohol, cellulose/starch derivatives, gum base, flavoring, active ingredient/hemp oil, tableting lubricants and powder flow agents, and sweeteners) as shown in Table 6: -
TABLE 6 Weight % Optimal Range Weight % A sugar alcohol or a blend of sugar alcohols 45.0-65.0 56.0 that can include one or more of the following: sorbitol, isomalt, xylitol, maltitol, mannitol or erythritol and one or more of the following: microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquisolid system. Gum Base 20.0-30.0 28.5 Flavoring in liquid and powder 5.0-11.0 9.0 Active ingredient(s)—hemp oil 0.5-10.0 2.5 Tableting lubricants and powder flow agents 1.5-5.0 3.5 Intensive sweeteners 0.2-0.6 0.5 Total 100.0 - The foregoing method of
FIG. 7 has been used successfully to produce a gum with an oil-form active ingredient, for example concentrated hemp oil that delivers cannabidiol (CBD) or with a resinous oil that delivers tetrahydrocannabinol (THC). The relative amounts of constituents (sugar alcohol, cellulose/starch derivatives, gum base, flavoring, active ingredient/hemp oil, and sweeteners) as shown in Table 7: -
TABLE 7 Weight % Optimal Range Weight % A sugar alcohol or a blend of sugar alcohols 45.0-65.0 55.5 that can include one or more of the following: sorbitol, isomalt, xylitol, maltitol, mannitol or erythritol Gum Base 25.0-40.0 33.0 Flavoring in liquid and powder 5.0-11.0 8.0 Active ingredient(s)—hemp oil 0.5-10.0 3.0 Intensive sweeteners 0.2-0.6 0.5 Total 100.0 - The foregoing method of
FIG. 8 has been used successfully to produce a gum with an oil-form active ingredient, for example concentrated hemp oil that delivers cannabidiol (CBD) or with a resinous oil that delivers tetrahydrocannabinol (THC). The relative amounts of constituents (sugar alcohol, cellulose/starch derivatives, gum base, flavoring, active ingredient/hemp oil, and sweeteners) as shown in Table 8: -
TABLE 8 Weight % Optimal Range Weight % A sugar alcohol or a blend of sugar alcohols 45.0-65.0 55.5 that can include one or more of the following: sorbitol, isomalt, xylitol, maltitol, mannitol or erythritol and one or more of the following: liquid flavor, microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquisolid system. Gum Base 25.0-40.0 33.0 Flavoring in liquid and powder 5.0-11.0 8.0 Active ingredient(s)—hemp oil 0.5-10.0 3.0 Intensive sweeteners 0.2-0.6 0.5 Total 100.0 - It should now be apparent that the above described method preserves the efficacy of the active ingredient(s) by avoiding exposure to high heat during mixing, or to extreme cold during milling, either of which can degrade the active's efficacy. Moreover, the active ingredient(s) even when provided in oil form can be mixed directly into the other powder ingredients and tableted, rather than spray-dried onto a powder carrier for tableting as with the prior art methods.
- The foregoing disclosure of embodiments of the present invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Many variations and modifications of the embodiments described herein will be obvious to one of ordinary skill in the art in light of the above disclosure. The scope of the invention is to be defined only by the claims, and by their equivalents.
Claims (14)
1-24. (canceled)
25. A composition comprising: a sugar alcohol, a blend of sugar alcohols, a sugar or blend of sugars, a gum base, flavoring, one or more active ingredients, tableting lubricants, powder flow agents, sweeteners and combinations thereof.
26. The composition of claim 25 , wherein the composition comprises:
a sugar alcohol or a blend of sugar alcohols, a sugar, a blend of sugars and combinations thereof, from about 20% to about 90% by weight of the total weight of the composition;
a gum base from about 10% to about 60% by weight of the total weight of the composition;
a flavoring from about 0.1% to about 30% by weight of the total weight of the composition;
a tableting lubricant and/or powder flow agents from about 0.1% to about 20% by weight of the total weight of the composition;
an intensive sweetner(s) from about 0.01% to about 15% by weight of the total weight of the composition;
an active ingredient from about 0.01% to about 40% by weight of the total weight of the composition; and,
combinations thereof.
27. The composition of claim 26 , wherein the composition comprises:
a sugar alcohol, a blend of sugar alcohols, a sugar, a blend of sugars and combinations thereof, from about 40% to about 85% by weight of the total weight of the composition;
a gum base from about 15% to about 35% by weight of the total weight of the composition;
a flavoring from about 1% to about 25% by weight of the total weight of the composition;
a tableting lubricant and/or powder flow agents from about 1% to about 10% by weight of the total weight of the composition;
an intensive sweetner(s) from about 0.1% to about 10% by weight of the total weight of the composition;
an active ingredient from about 1% to about 30% by weight of the total weight of the composition; and,
combinations thereof.
28. The composition of claim 27 , wherein the composition comprises:
a sugar alcohol, a blend of sugar alcohols, a sugar, a blend of sugars and combinations thereof, from about 40% to about 80% by weight of the total weight of the composition;
a gum base from about 15% to about 40% by weight of the total weight of the composition;
a flavoring from about 1% to about 20% by weight of the total weight of the composition;
a tableting lubricant and/or powder flow agents from about 0.5% to about 15% by weight of the total weight of the composition;
an intensive sweetner(s) from about 0.1% to about 5% by weight of the total weight of the composition;
an active ingredient from about 0.5% to about 30% by weight of the total weight of the composition; and,
combinations thereof.
29. The composition of claim 25 , wherein the active ingredient is chitosan, caffeine, cannabidiol (CBD) or hemp oil.
30. The composition of claim 25 , wherein the sugar alcohol or the blend of sugar alcohols comprise sorbitol, isomalt, xylitol, maltitol, mannitol, erythritol and combinations thereof.
31. The composition of claim 25 , wherein the sugar or the blend of sugars comprises: dextrose, sucrose, fructose, glucose and combinations thereof.
32. The composition of claim 25 , further comprising: microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquidsolid systems.
33. A composition comprising: a sugar alcohol, a blend of sugar alcohols, a sugar or blend of sugars, a gum base, flavoring, one or more active ingredients, tableting lubricants, powder flow agents, sweeteners, microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquidsolid system, and combinations thereof.
34. The composition of claim 33 , wherein the composition comprises:
a sugar alcohol or a blend of sugar alcohols, microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquidsolid system, and combinations thereof from about 20% to about 80% by weight of the total weight of the composition;
a gum base from about 10% to about 60% by weight of the total weight of the composition;
a flavoring from about 1% to about 30% by weight of the total weight of the composition;
a tableting lubricant and/or powder flow agents from about 0.1% to about 20% by weight of the total weight of the composition;
an intensive sweetner(s) from about 0.01% to about 10% by weight of the total weight of the composition;
an active ingredient from about 0.01% to about 40% by weight of the total weight of the composition; and,
combinations thereof.
35. The composition of claim 34 , wherein the composition comprises:
a sugar alcohol, a blend of sugar alcohols, a sugar, a blend of sugars, microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquidsolid system, and combinations thereof, from about 40% to about 85% by weight of the total weight of the composition;
a gum base from about 15% to about 55% by weight of the total weight of the composition;
a flavoring from about 1% to about 25% by weight of the total weight of the composition;
a tableting lubricant and/or powder flow agents from about 1% to about 10% by weight of the total weight of the composition;
an intensive sweetner(s) from about 0.1% to about 10% by weight of the total weight of the composition;
an active ingredient from about 1% to about 30% by weight of the total weight of the composition; and,
combinations thereof.
36. The composition of claim 35 , wherein the composition comprises:
a sugar alcohol, a blend of sugar alcohols, a sugar, a blend of sugars, microcrystalline cellulose, dextrose, modified starch, starch derivatives or other liquidsolid system, and combinations thereof, from about 40% to about 75% by weight of the total weight of the composition;
a gum base from about 15% to about 50% by weight of the total weight of the composition;
a flavoring from about 1% to about 15% by weight of the total weight of the composition;
a tableting lubricant and/or powder flow agents from about 0.5% to about 15% by weight of the total weight of the composition;
an intensive sweetner(s) from about 0.5% to about 7.5% by weight of the total weight of the composition;
an active ingredient from about 0.5% to about 20% by weight of the total weight of the composition; and,
combinations thereof.
37. The composition of claim 33 , wherein the active ingredient is cannabidiol (CBD) or hemp oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/499,348 US20220023203A1 (en) | 2014-06-05 | 2021-10-12 | Method for manufacturing medicated chewing gum without cooling |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462008211P | 2014-06-05 | 2014-06-05 | |
US14/732,072 US9744128B2 (en) | 2014-06-05 | 2015-06-05 | Method for manufacturing medicated chewing gum without cooling |
US15/622,632 US10463612B2 (en) | 2014-06-05 | 2017-06-14 | Method for manufacturing medicated chewing gum without cooling |
US16/673,393 US11154497B2 (en) | 2014-06-05 | 2019-11-04 | Method for manufacturing medicated chewing gum without cooling |
US17/499,348 US20220023203A1 (en) | 2014-06-05 | 2021-10-12 | Method for manufacturing medicated chewing gum without cooling |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date | |
---|---|---|---|---|
US16/673,393 Continuation US11154497B2 (en) | 2014-06-05 | 2019-11-04 | Method for manufacturing medicated chewing gum without cooling |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220023203A1 true US20220023203A1 (en) | 2022-01-27 |
Family
ID=57451319
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/732,072 Active US9744128B2 (en) | 2014-06-05 | 2015-06-05 | Method for manufacturing medicated chewing gum without cooling |
US15/622,584 Abandoned US20170273902A1 (en) | 2014-06-05 | 2017-06-14 | Method for manufacturing medicated chewing gum without cooling |
US15/622,676 Abandoned US20170273903A1 (en) | 2014-06-05 | 2017-06-14 | Method for manufacturing medicated chewing gum without cooling |
US15/622,632 Active US10463612B2 (en) | 2014-06-05 | 2017-06-14 | Method for manufacturing medicated chewing gum without cooling |
US16/673,393 Active US11154497B2 (en) | 2014-06-05 | 2019-11-04 | Method for manufacturing medicated chewing gum without cooling |
US17/499,348 Pending US20220023203A1 (en) | 2014-06-05 | 2021-10-12 | Method for manufacturing medicated chewing gum without cooling |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/732,072 Active US9744128B2 (en) | 2014-06-05 | 2015-06-05 | Method for manufacturing medicated chewing gum without cooling |
US15/622,584 Abandoned US20170273902A1 (en) | 2014-06-05 | 2017-06-14 | Method for manufacturing medicated chewing gum without cooling |
US15/622,676 Abandoned US20170273903A1 (en) | 2014-06-05 | 2017-06-14 | Method for manufacturing medicated chewing gum without cooling |
US15/622,632 Active US10463612B2 (en) | 2014-06-05 | 2017-06-14 | Method for manufacturing medicated chewing gum without cooling |
US16/673,393 Active US11154497B2 (en) | 2014-06-05 | 2019-11-04 | Method for manufacturing medicated chewing gum without cooling |
Country Status (1)
Country | Link |
---|---|
US (6) | US9744128B2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9744128B2 (en) | 2014-06-05 | 2017-08-29 | Mastix LLC | Method for manufacturing medicated chewing gum without cooling |
US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
BR112019023307A2 (en) * | 2017-06-05 | 2020-06-16 | Intercontinental Great Brands Llc | MASKING GUM COMPOSITIONS AND METHODS TO PRODUCE THE SAME |
US11083765B2 (en) * | 2017-12-15 | 2021-08-10 | Andrew Scott Davis | Hemp leaf chew composition and method for producing |
US20200069581A1 (en) * | 2018-09-04 | 2020-03-05 | Babak Ghalili | Cannabinoid and anesthetic gum and lozenge compositions and methods |
US11191720B2 (en) | 2019-01-25 | 2021-12-07 | Nordiccan A/S | Chewing gum with improved delivery of cannabinoids |
AU2019424547A1 (en) * | 2019-01-25 | 2021-07-08 | Nordiccan A/S | Cannabinoid chewing gum with improved release of cannabinoids |
US11013685B2 (en) | 2019-01-25 | 2021-05-25 | Nordiccan A/S | Cannabinoid chewing gum with improved release of cannabinoids |
US11406593B2 (en) | 2019-01-25 | 2022-08-09 | Nordiccan A/S | Cannabinoid chewing gum with high intensity sweeteners |
CN113423280A (en) * | 2019-01-25 | 2021-09-21 | 诺狄更斯公司 | Cannabinoid chewing gum with sugar alcohol |
US11154496B2 (en) | 2019-01-25 | 2021-10-26 | Nordiccan A/S | Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
WO2020151793A1 (en) * | 2019-01-25 | 2020-07-30 | Medcan Pharma A/S | Chewing gum with improved delivery of cannabinoids |
US11166910B2 (en) | 2019-01-25 | 2021-11-09 | Nordiccan A/S | Cannabinoid chewing gum with sugar alcohols |
US10799450B2 (en) | 2019-03-01 | 2020-10-13 | Medcan Pharma A/S | Tableted cannabinoid chewing gum with layered structure |
US11253473B2 (en) * | 2019-03-01 | 2022-02-22 | Nordiccan A/S | Method of producing tableted cannabinoid chewing gum |
US11471405B2 (en) | 2019-03-01 | 2022-10-18 | Nordiccan A/S | Tableted chewing gum with enhanced delivery of cannabinoids |
US10933017B2 (en) | 2019-03-01 | 2021-03-02 | Nordiccan A/S | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
WO2020177820A1 (en) | 2019-03-01 | 2020-09-10 | Medcan Pharma A/S | Method of producing tableted cannabinoid chewing gum |
US11464827B2 (en) * | 2020-03-10 | 2022-10-11 | Anewsha Holding Group Llc | Antiviral pharmaceutical compositions and method of manufacturing |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4370350A (en) | 1980-04-28 | 1983-01-25 | Wm. Wrigley Jr. Company | Chewing gum method |
US4753805A (en) | 1984-01-31 | 1988-06-28 | Warner-Lambert Company | Tabletted chewing gum composition and method of preparation |
CA1240875A (en) * | 1984-01-31 | 1988-08-23 | Subraman R. Cherukuri | Tableted chewing gum composition and method of preparation |
US4975270A (en) | 1987-04-21 | 1990-12-04 | Nabisco Brands, Inc. | Elastomer encased active ingredients |
IT1274034B (en) | 1994-07-26 | 1997-07-14 | Applied Pharma Res | PHARMACEUTICAL COMPOSITIONS BASED ON RUBBER TO BE CHEWED AND PROCEDURE FOR THEIR PREPARATION |
US5866179A (en) | 1996-05-03 | 1999-02-02 | Avant-Garde Technologies & Products S.A. | Medicated chewing gum and a process for preparation thereof |
US5803081A (en) * | 1996-06-28 | 1998-09-08 | Regent Court Technologies | Tobacco and related products |
US6344222B1 (en) | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
US6322828B1 (en) * | 1999-09-13 | 2001-11-27 | Deseret Laboratories, Inc. | Process for manufacturing a pharmaceutical chewing gum |
US6582738B2 (en) | 1999-09-13 | 2003-06-24 | Deseret Laboratories, Inc. | Process for preparing chewing gum containing a nutritional supplement |
EP1311240A1 (en) | 2000-08-14 | 2003-05-21 | Fertin Pharma A/S | Method for preparation of chewing gum with customer acceptable taste |
SE0102197D0 (en) * | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
US7208186B2 (en) * | 2001-09-18 | 2007-04-24 | Spi Pharma, Inc. | Chewing gum formulation and method of making the same |
FI20020333A0 (en) | 2002-02-20 | 2002-02-20 | Tomi Jaervinen | Novel Complexes of Methylated Cyclodextrin |
EP1350434A1 (en) | 2002-04-05 | 2003-10-08 | Gum Base Co. S.p.A. | Chewing gum in powder form and method of preparation |
CA2491295C (en) | 2002-07-02 | 2010-10-12 | Gumlink A/S | Compressed chewing gum |
US20060003050A1 (en) * | 2002-07-02 | 2006-01-05 | Vibeke Nissen | Compressed chewing gum tablet II |
MXPA05007346A (en) * | 2003-02-04 | 2005-09-30 | Gumlink As | Compressed chewing gum tablet. |
GB0416861D0 (en) | 2004-07-29 | 2004-09-01 | Quadrant Drug Delivery Ltd | Composition |
MX2007002336A (en) | 2004-08-25 | 2008-03-10 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition. |
US20060177415A1 (en) | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
ITME20040015A1 (en) | 2004-12-07 | 2005-03-07 | Vincenzo Savica | CHEWING GUM, RUBBER CANDIES, TABLETS, SLOW TABLETS OF CHELANTI PHOSPHATE AND / OR PHOSPHORUS SALIVAR AND CAPSULES WITH SLOW RELEASE OF CHELANTS PHOSPHATE AND / OR PHOSPHORUS AT GASTROENTERIC LEVEL. |
FR2882366B1 (en) | 2005-02-18 | 2008-04-18 | Coletica Sa | RETICULATED CARBOHYDRATE POLYMER, IN PARTICULAR BASED ON POLYSACCHARIDES AND / OR POLYOLS |
SI2280687T1 (en) | 2008-03-26 | 2019-09-30 | Stichting Sanammad | Chewing gum compositions comprising cannabinoids |
US20110070286A1 (en) * | 2009-09-24 | 2011-03-24 | Andreas Hugerth | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
US9744128B2 (en) | 2014-06-05 | 2017-08-29 | Mastix LLC | Method for manufacturing medicated chewing gum without cooling |
-
2015
- 2015-06-05 US US14/732,072 patent/US9744128B2/en active Active
-
2017
- 2017-06-14 US US15/622,584 patent/US20170273902A1/en not_active Abandoned
- 2017-06-14 US US15/622,676 patent/US20170273903A1/en not_active Abandoned
- 2017-06-14 US US15/622,632 patent/US10463612B2/en active Active
-
2019
- 2019-11-04 US US16/673,393 patent/US11154497B2/en active Active
-
2021
- 2021-10-12 US US17/499,348 patent/US20220023203A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20170273903A1 (en) | 2017-09-28 |
US11154497B2 (en) | 2021-10-26 |
US20200129427A1 (en) | 2020-04-30 |
US20160354310A1 (en) | 2016-12-08 |
US20170281539A1 (en) | 2017-10-05 |
US20170273902A1 (en) | 2017-09-28 |
US9744128B2 (en) | 2017-08-29 |
US10463612B2 (en) | 2019-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220023203A1 (en) | Method for manufacturing medicated chewing gum without cooling | |
US11529329B2 (en) | Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin | |
EP2334202B1 (en) | Tabletting of ervthritol | |
KR101003019B1 (en) | Chewing gum in powder form and a method of preparation | |
JP3452802B2 (en) | Method for producing composition for tableting using erythritol | |
EP1538921B1 (en) | Chewing gum formulation and method of making the same | |
US20180206538A1 (en) | Sugar compositions for tableting by direct compression | |
EP1853124B1 (en) | Process for making bouillon or seasoning cubes | |
JP5110810B2 (en) | Sugar alcohol powder composition for tableting | |
US20120149784A1 (en) | Tabletting of erythritol and isomalt | |
EP1721620A1 (en) | Directly-compressible xylitol powder | |
CN100333657C (en) | Gum base composition | |
KR101644997B1 (en) | Method for manufacturing tablet containing cocoa powder and tablet by the same | |
JPH08256695A (en) | Granule for low-caloric tablet confectionery, its production and tablet confectionery using the same granule | |
US20130072578A1 (en) | Orodispersible tablets of erythritol and isomalt | |
KR100713138B1 (en) | Process for preparing tablet gum | |
JP2942411B2 (en) | Poorly soluble tableted food and its manufacturing method | |
JPH0767541A (en) | Gum tablet | |
CN112401231A (en) | A method for preparing propolis composition and propolis composition prepared by the method | |
JP2003250493A (en) | Anticavity food comprising granulated substance of barley young leaf | |
JP2000245396A (en) | Production of food or medicine comprising granular form and tablet form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |